These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 12637581)

  • 1. Sulindac sulfide is a noncompetitive gamma-secretase inhibitor that preferentially reduces Abeta 42 generation.
    Takahashi Y; Hayashi I; Tominari Y; Rikimaru K; Morohashi Y; Kan T; Natsugari H; Fukuyama T; Tomita T; Iwatsubo T
    J Biol Chem; 2003 May; 278(20):18664-70. PubMed ID: 12637581
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A subset of NSAIDs lower amyloidogenic Abeta42 independently of cyclooxygenase activity.
    Weggen S; Eriksen JL; Das P; Sagi SA; Wang R; Pietrzik CU; Findlay KA; Smith TE; Murphy MP; Bulter T; Kang DE; Marquez-Sterling N; Golde TE; Koo EH
    Nature; 2001 Nov; 414(6860):212-6. PubMed ID: 11700559
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Abeta42-lowering nonsteroidal anti-inflammatory drugs preserve intramembrane cleavage of the amyloid precursor protein (APP) and ErbB-4 receptor and signaling through the APP intracellular domain.
    Weggen S; Eriksen JL; Sagi SA; Pietrzik CU; Golde TE; Koo EH
    J Biol Chem; 2003 Aug; 278(33):30748-54. PubMed ID: 12777371
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Purification and characterization of the human gamma-secretase complex.
    Fraering PC; Ye W; Strub JM; Dolios G; LaVoie MJ; Ostaszewski BL; van Dorsselaer A; Wang R; Selkoe DJ; Wolfe MS
    Biochemistry; 2004 Aug; 43(30):9774-89. PubMed ID: 15274632
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evidence that nonsteroidal anti-inflammatory drugs decrease amyloid beta 42 production by direct modulation of gamma-secretase activity.
    Weggen S; Eriksen JL; Sagi SA; Pietrzik CU; Ozols V; Fauq A; Golde TE; Koo EH
    J Biol Chem; 2003 Aug; 278(34):31831-7. PubMed ID: 12805356
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Second generation γ-secretase modulators exhibit different modulation of Notch β and Aβ production.
    Wanngren J; Ottervald J; Parpal S; Portelius E; Strömberg K; Borgegård T; Klintenberg R; Juréus A; Blomqvist J; Blennow K; Zetterberg H; Lundkvist J; Rosqvist S; Karlström H
    J Biol Chem; 2012 Sep; 287(39):32640-50. PubMed ID: 22851182
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Independent generation of Abeta42 and Abeta38 peptide species by gamma-secretase.
    Czirr E; Cottrell BA; Leuchtenberger S; Kukar T; Ladd TB; Esselmann H; Paul S; Schubenel R; Torpey JW; Pietrzik CU; Golde TE; Wiltfang J; Baumann K; Koo EH; Weggen S
    J Biol Chem; 2008 Jun; 283(25):17049-54. PubMed ID: 18426795
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nonsteroidal anti-inflammatory drugs can lower amyloidogenic Abeta42 by inhibiting Rho.
    Zhou Y; Su Y; Li B; Liu F; Ryder JW; Wu X; Gonzalez-DeWhitt PA; Gelfanova V; Hale JE; May PC; Paul SM; Ni B
    Science; 2003 Nov; 302(5648):1215-7. PubMed ID: 14615541
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selected non-steroidal anti-inflammatory drugs and their derivatives target gamma-secretase at a novel site. Evidence for an allosteric mechanism.
    Beher D; Clarke EE; Wrigley JD; Martin AC; Nadin A; Churcher I; Shearman MS
    J Biol Chem; 2004 Oct; 279(42):43419-26. PubMed ID: 15304503
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Insensitivity to Abeta42-lowering nonsteroidal anti-inflammatory drugs and gamma-secretase inhibitors is common among aggressive presenilin-1 mutations.
    Czirr E; Leuchtenberger S; Dorner-Ciossek C; Schneider A; Jucker M; Koo EH; Pietrzik CU; Baumann K; Weggen S
    J Biol Chem; 2007 Aug; 282(34):24504-13. PubMed ID: 17573346
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of sulindac sulfide on the membrane architecture and the activity of gamma-secretase.
    Gamerdinger M; Clement AB; Behl C
    Neuropharmacology; 2008 May; 54(6):998-1005. PubMed ID: 18359496
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Amyloid beta 42 peptide (Abeta42)-lowering compounds directly bind to Abeta and interfere with amyloid precursor protein (APP) transmembrane dimerization.
    Richter L; Munter LM; Ness J; Hildebrand PW; Dasari M; Unterreitmeier S; Bulic B; Beyermann M; Gust R; Reif B; Weggen S; Langosch D; Multhaup G
    Proc Natl Acad Sci U S A; 2010 Aug; 107(33):14597-602. PubMed ID: 20679249
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Signal peptide peptidase and gamma-secretase share equivalent inhibitor binding pharmacology.
    Iben LG; Olson RE; Balanda LA; Jayachandra S; Robertson BJ; Hay V; Corradi J; Prasad CV; Zaczek R; Albright CF; Toyn JH
    J Biol Chem; 2007 Dec; 282(51):36829-36. PubMed ID: 17932033
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Calpain inhibitor I increases beta-amyloid peptide production by inhibiting the degradation of the substrate of gamma-secretase. Evidence that substrate availability limits beta-amyloid peptide production.
    Zhang L; Song L; Parker EM
    J Biol Chem; 1999 Mar; 274(13):8966-72. PubMed ID: 10085142
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biochemical characterization of the gamma-secretase activity that produces beta-amyloid peptides.
    Zhang L; Song L; Terracina G; Liu Y; Pramanik B; Parker E
    Biochemistry; 2001 Apr; 40(16):5049-55. PubMed ID: 11305921
    [TBL] [Abstract][Full Text] [Related]  

  • 16. NSAIDs and enantiomers of flurbiprofen target gamma-secretase and lower Abeta 42 in vivo.
    Eriksen JL; Sagi SA; Smith TE; Weggen S; Das P; McLendon DC; Ozols VV; Jessing KW; Zavitz KH; Koo EH; Golde TE
    J Clin Invest; 2003 Aug; 112(3):440-9. PubMed ID: 12897211
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Substrate sequence influences γ-secretase modulator activity, role of the transmembrane domain of the amyloid precursor protein.
    Sagi SA; Lessard CB; Winden KD; Maruyama H; Koo JC; Weggen S; Kukar TL; Golde TE; Koo EH
    J Biol Chem; 2011 Nov; 286(46):39794-803. PubMed ID: 21868380
    [TBL] [Abstract][Full Text] [Related]  

  • 18. First and second generation γ-secretase modulators (GSMs) modulate amyloid-β (Aβ) peptide production through different mechanisms.
    Borgegard T; Juréus A; Olsson F; Rosqvist S; Sabirsh A; Rotticci D; Paulsen K; Klintenberg R; Yan H; Waldman M; Stromberg K; Nord J; Johansson J; Regner A; Parpal S; Malinowsky D; Radesater AC; Li T; Singh R; Eriksson H; Lundkvist J
    J Biol Chem; 2012 Apr; 287(15):11810-9. PubMed ID: 22334705
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Potent γ-secretase inhibitors/modulators interact with amyloid-β fibrils but do not inhibit fibrillation: a high-resolution NMR study.
    Yesuvadian R; Krishnamoorthy J; Ramamoorthy A; Bhunia A
    Biochem Biophys Res Commun; 2014 May; 447(4):590-5. PubMed ID: 24747079
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Beta-secretase cleavage at amino acid residue 34 in the amyloid beta peptide is dependent upon gamma-secretase activity.
    Shi XP; Tugusheva K; Bruce JE; Lucka A; Wu GX; Chen-Dodson E; Price E; Li Y; Xu M; Huang Q; Sardana MK; Hazuda DJ
    J Biol Chem; 2003 Jun; 278(23):21286-94. PubMed ID: 12665519
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.